GENEVA, Sept. 18 -- AVEXO PHARMACEUTICALS INC filed a patent application (US2026/017824) for “PAD3 ACTIVITY MODULATORS AND THEIR USE IN TREATING IMMUNE-DRIVEN CONDITIONS”. With publication no. WO/2026/187987, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: none
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....